title: [Fever in the first 48 hours of an acute myocardial infarct treated with fibrinolytics--an indicator of nonreperfusion of the coronary vessels?].
abstract: Fever in the first days of acute myocardial infarction (AMI) is a very common clinical feature, being its prognostic value unquestionable. As infarction area reduction implies a less important fever reaction in the first days of AMI, we believe that thrombolytic therapy would result in a decline of body temperature of patients so treated. That is why we tried to identify such a correlation, and demonstrate the value of normal body temperature as indicative of reperfusion. We studied retrospectively 68 patients (10 F and 58 M, 57.1 +/- 9.6 years) survivors of AMI (I-II KK classes), with (TT) or without (NT) thrombolytic therapy. In NT group, there was an axillary temperature (AX T) higher than 37 degrees C at the first 24 hours in 21 patients (62%); TT group only had 10 patients (30%) with AX T over 37 degrees C (p < 0.01). NT group CK mean peak was 856 +/- 610 U.I./l in patients having AX T > 37 degrees C, and 436 +/- 233 U.I./l when AX T was < or = 37 degrees C (p < 0.05); in TT group there was no difference between CK peak means when AX T was > or < or = 37 degrees C (1508 +/- 1210 U.I./l vs 1406 +/- 1149 U.I./l, respectively) (NA). We established statistic difference between AX T of 15 patients which CK peak was reached after 10 hours over onset of AMI (37.59 +/- 0.36 degrees C) and those (19 p) with CK peak before 10 hours (37.17 +/- 0.60 degrees C) (p < 0.05). NT group presented then more febrile patients than did TT group.
  
  
  CONCLUSIONS
  in NT group there was a positive relation between AX T and CK peak level; AX T > 37 degrees C was less frequent in TT group and was as much light when CK peak was more precocious. These results suggest that in thrombolytic treated patients the absence of fever in the first 48 hours may constitute one more coronary reperfusion criterion.
authors.affiliation: Serviço de Cardiologia do Hospital Distrital de V. Franca de Xira.
authors.forename: D
authors.initials: D
authors.lastname: Pereira
authors.forename: J
authors.initials: J
authors.lastname: Linder
authors.forename: C
authors.initials: C
authors.lastname: Rabaçal
authors.forename: H
authors.initials: H
authors.lastname: Ribeiro
authors.forename: L
authors.initials: L
authors.lastname: Nuno
authors.forename: E
authors.initials: E
authors.lastname: Carvalho
authors.forename: J S
authors.initials: JS
authors.lastname: Afonso
authors.forename: J S
authors.initials: JS
authors.lastname: Fernandes
mesh_terms: D000328:Adult; D000368:Aged; D001365:Axilla; D001831:Body Temperature; D003326:Coronary Circulation / Q000187:drug effects*; D005260:Female; D005334:Fever / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D011379:Prognosis; D012189:Retrospective Studies; D015912:Thrombolytic Therapy; D013997:Time Factors
vernacular_title: Febre nas primeiras 48 horas do enfarte agudo do miocárdio tratado com fibrinolíticos--indicador de não reperfusão das coronárias?